All companies
GeneDx Holdings Corp. logo

What smart money is saying about GeneDx Holdings Corp.United States flag

WGS · Healthcare · Medical - Healthcare Information Services · Market cap $1.83B

1 fund in our archive has pitched GeneDx Holdings Corp. — most recently Amati Global Investors WS Amati Global Innovation Fund (B Share Class) in June 2026.

Company profile

GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.

2
Reported positions
0
Bought
0
Sold
2
Letters

Fund activity · 2 positions

  • HoldsAlger.com Alger Small Cap Focus Fund
    June 2026
    Karman Holdings Inc., GeneDx Holdings Corp., and Forte Biosciences Inc. were among the top detractors from performance.
    Read the letterGeneDx Holdings Corp.
  • HoldsAmati Global Investors WS Amati Global Innovation Fund (B Share Class)
    June 2026
    The third most significant contributor, GeneDX, operates in a completely different market but experienced a strong bounce after a period of weakness through the early part of the year.
    Read the letterGeneDx Holdings Corp.

Fund coverage · 1 thesis

  • Amati Global Investors WS Amati Global Innovation Fund (B Share Class)
    June 2026

    GeneDx Holdings Corp. operates a genetic sequencing diagnostics platform positioned to benefit from wider adoption, reimbursement, and improving economics of testing.

    Read the full thesis

Read every full thesis on GeneDx Holdings Corp.

Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.

View plans
Share this ledger